Stefan Doboczky will assume the executive chairmanship of Hovione on April 1, 2027. Until that date, Doboczky will continue to carry out his current duties at the company.
Doboczky is currently the chairman of the board of directors of Hovione Holding AG, a position he has held since 2024. In that role, he played a fundamental role in defining the company's strategy and vision.
With this change, Doboczky will leave the position of chairman of the board of directors when he assumes the new executive role. The transition marks a significant change in the company's leadership structure.
Hovione is a pharmaceutical company. The article does not provide additional details about the company or about who may fill the position that Doboczky will leave on the board of directors.




